Control of a Community-Wide Outbreak of Hepatitis A by Mass Vaccination with Inactivated Hepatitis A Vaccine
β Scribed by C. Zamir; S. Rishpon; D. Zamir; A. Leventhal; N. Rimon; E. Ben-Porath
- Book ID
- 106273220
- Publisher
- Springer
- Year
- 2001
- Tongue
- English
- Weight
- 74 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0934-9723
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract During a large communityβwide outbreak of hepatitis A in two adjoining villages in Slovakia with a total of 5,000 inhabitants we administered to schoolchildren the first commercially available vaccine against hepatitis A (HAVRIX(tm), SmithβKline Beecham Biologicals, Rixensart, Belgium)
## Abstract The aim of this study was to predict the longβterm protection induced after immunisation with inactivated, aluminiumβfree virosome hepatitis A vaccine. The study population consisted of adult volunteers enrolled in four different clinical trials. Lower 95% confidence interval limits and
Hepatitis A virus (HAV) strain CR326, adapted to grow in LLC-MK2 cells, was highly purified, inactivated with formalin, adsorbed to alum, and tested for capacity to induce antibody to HAV in both mice and marmosets. The minimum dose of HAV antigen necessary to produce antibody in 50% of mice was 10
Very few studies with inactivated hepatitis A vaccines were designed for long-term follow-up of antibody persistence. Based on the serological data from these vaccine trials, mathematical models were developed to predict the decrease of anti-hepatitis A virus (anti-HAV) antibodies after vaccination.